199 related articles for article (PubMed ID: 21147213)
21. Efficient Therapeutic Function and Mechanisms of Human Polyclonal CD8
Sun J; Yang Y; Huo X; Zhu B; Li Z; Jiang X; Xie R; Gao L; Sun Y; Fan H; Zhu Y; Yang J
J Immunol Res; 2019; 2019():8575407. PubMed ID: 30915372
[TBL] [Abstract][Full Text] [Related]
22. Aurintricarboxylic acid promotes the conversion of naive CD4+CD25- T cells into Foxp3-expressing regulatory T cells.
Lim DG; Park YH; Kim SE; Kim YH; Park CS; Kim SC; Park CG; Han DJ
Int Immunol; 2011 Sep; 23(9):583-92. PubMed ID: 21750147
[TBL] [Abstract][Full Text] [Related]
23. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats.
Wang GY; Zhang Q; Yang Y; Chen WJ; Liu W; Jiang N; Chen GH
Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):203-8. PubMed ID: 22484590
[TBL] [Abstract][Full Text] [Related]
24. Enhanced suppression of the xenogeneic T-cell response in vitro by xenoantigen stimulated and expanded regulatory T cells.
Jin X; Wang Y; Hawthorne WJ; Hu M; Yi S; O'Connell P
Transplantation; 2014 Jan; 97(1):30-8. PubMed ID: 24092378
[TBL] [Abstract][Full Text] [Related]
25. Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells.
Prochazkova J; Fric J; Pokorna K; Neuwirth A; Krulova M; Zajicova A; Holan V
Immunology; 2009 Sep; 128(1 Suppl):e670-8. PubMed ID: 19740328
[TBL] [Abstract][Full Text] [Related]
26. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.
Li Y; Chen HL; Bannick N; Henry M; Holm AN; Metwali A; Urban JF; Rothman PB; Weiner GJ; Blazar BR; Elliott DE; Ince MN
J Immunol; 2015 Feb; 194(3):1011-20. PubMed ID: 25527786
[TBL] [Abstract][Full Text] [Related]
27. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors.
Zheng SG; Gray JD; Ohtsuka K; Yamagiwa S; Horwitz DA
J Immunol; 2002 Oct; 169(8):4183-9. PubMed ID: 12370347
[TBL] [Abstract][Full Text] [Related]
28. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.
Turnquist HR; Raimondi G; Zahorchak AF; Fischer RT; Wang Z; Thomson AW
J Immunol; 2007 Jun; 178(11):7018-31. PubMed ID: 17513751
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
30. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice.
van Rijn RS; Simonetti ER; Hagenbeek A; Hogenes MC; de Weger RA; Canninga-van Dijk MR; Weijer K; Spits H; Storm G; van Bloois L; Rijkers G; Martens AC; Ebeling SB
Blood; 2003 Oct; 102(7):2522-31. PubMed ID: 12791667
[TBL] [Abstract][Full Text] [Related]
31. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
33. Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4
Giang S; Horwitz DA; Bickerton S; La Cava A
Front Immunol; 2021; 12():628059. PubMed ID: 34122401
[TBL] [Abstract][Full Text] [Related]
34. Rapamycin combined with TGF-β converts human invariant NKT cells into suppressive Foxp3+ regulatory cells.
Moreira-Teixeira L; Resende M; Devergne O; Herbeuval JP; Hermine O; Schneider E; Dy M; Cordeiro-da-Silva A; Leite-de-Moraes MC
J Immunol; 2012 Jan; 188(2):624-31. PubMed ID: 22156591
[TBL] [Abstract][Full Text] [Related]
35. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
[TBL] [Abstract][Full Text] [Related]
36. Levels of TGF-β(1) in serum and culture supernatants of CD4(+)CD25 (+) T cells from patients with non-segmental vitiligo.
Tu CX; Jin WW; Lin M; Wang ZH; Man MQ
Arch Dermatol Res; 2011 Nov; 303(9):685-9. PubMed ID: 21644048
[TBL] [Abstract][Full Text] [Related]
37. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.
Zheng SG; Wang JH; Gray JD; Soucier H; Horwitz DA
J Immunol; 2004 May; 172(9):5213-21. PubMed ID: 15100259
[TBL] [Abstract][Full Text] [Related]
38. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
39. Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation.
Wang X; Wang W; Xu J; Le Q
Transplant Proc; 2013 Mar; 45(2):528-37. PubMed ID: 23267787
[TBL] [Abstract][Full Text] [Related]
40. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]